# Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Source: https://onco.cc/trials/nct07635290/  
OnCo record `nct07635290` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of cadonilimab and anlotinib in gallbladder cancer and other biliary tract cancers, run by West China Hospital, active and no longer recruiting.

## Summary

Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer is a phase 2 interventional study registered as NCT07635290 by West China Hospital, with a registry enrolment figure of 26 participants, started 2026-06-03 and due to reach its primary completion in 2027-06-30. Interventions recorded: Anlotinib + Cadonilimab, PULSAR. Conditions listed: Previously Treated, Advanced, Biliary Tract Cancers. Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07635290
- Phase: 2
- Setting: A Phase II Clinical Trial of Anlotinib Combined With Cadonilimab and PULSAR in Previously Treated Advanced Unresectable or Metastatic Biliary Tract Cancer
- Sponsor: West China Hospital
- Enrolled: 26

## Sources

- ClinicalTrials.gov NCT07635290: https://clinicaltrials.gov/study/NCT07635290

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Bispecific antibodies](https://onco.cc/technologies/bispecific-antibody/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Anlotinib](https://onco.cc/drugs/anlotinib/), [Cadonilimab](https://onco.cc/drugs/cadonilimab/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07635290.json